Bulletin
Investor Alert

Chinook Therapeutics Inc.

NAS: KDNY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207469562/composite

$

21.73

Change

+1.29 +6.29%

Volume

Volume 6,098

Aug 5, 2022, 5:17 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207469562/composite

Previous close

$ 20.37

$ 20.44

Change

+0.07 +0.34%

Day low

Day high

$19.77

$21.11

Open
Open: 20.17

52 week low

52 week high

$10.48

$21.11

Open

Market cap

$1.26B

Average volume

694,173

P/E ratio

N/A

Rev. per Employee

$391,094

EPS

-2.06

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/kdny

MarketWatch News on KDNY

  1. Chinook Therapeutics started at buy with $30 stock price target at Stifel Nicolaus

    7:31 a.m. June 28, 2022

    - Tomi Kilgore

  2. Green Plains, Quotient Technology See Activist Action

    10:30 p.m. Jan. 21, 2022

    - Barron's Online

  3. Chinook Therapeutics initiated at Wedbush at outperform with $28 price target

    10:23 a.m. Jan. 6, 2021

    - Tonya Garcia

  4. Chinook Therapeutics started at outperform with $32 stock price target at Evercore ISI

    8:24 a.m. Nov. 2, 2020

    - Tomi Kilgore

  5. Chinook Therapeutics upgraded to outperform from perform at Oppenheimer

    8:45 a.m. Oct. 20, 2020

    - Tomi Kilgore

  6. Chinook Therapeutics started at outperform with $38 stock price target at SVB Leerink

    6:30 a.m. Oct. 7, 2020

    - Tomi Kilgore

  7. Aduro Biotech downgraded to perform from outperform at Oppenheimer

    9:00 a.m. June 3, 2019

    - Tomi Kilgore

  8. Harvard’s Stockpickers Are Beating Yale’s

    6:18 p.m. Feb. 13, 2019

    - Barron's Online

  9. Aduro Biotech started at outperform with $15 stock price target at Oppenheimer

    7:33 a.m. Oct. 31, 2017

    - Tomi Kilgore

  10. Why Biotech Looks Like a Good Bet in 2017

    3:04 p.m. Feb. 22, 2017

    - Barron's Online

  11. Dow, S&P 500 close higher, lifted by surge in mergers

    4:16 p.m. Oct. 24, 2016

    - Anora Mahmudova

  12. Aduro Biotech stock drops 22% after patient tested positive for listeria

    8:33 a.m. Oct. 24, 2016

    - Emma Court

  13. Aduro Biotech says FDA put trials on partial clinical hold after patient tested positively for listeria

    8:33 a.m. Oct. 24, 2016

    - Emma Court

  14. Aduro Biotech halted after patient in clinical trial tested positive for listeria

    8:31 a.m. Oct. 24, 2016

    - Emma Court

  15. Aduro's stock resumes trade, tumbles 35% premarket after disappointing trial results

    8:52 a.m. May 16, 2016

    - Tomi Kilgore

  16. Aduro Biotech said late-stage pancreatic cancer drug missed primary endpoint

    8:39 a.m. May 16, 2016

    - Emma R. Court

  17. Aduro Biotech shares halted in premarke trade

    8:33 a.m. May 16, 2016

    - Ciara Linnane

  18. Aduro Biotech started at outperform with $30 stock price target at Cowen & Co.

    10:15 a.m. March 2, 2016

    - Tomi Kilgore

  19. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/kdny

Other News on KDNY

  1. Checking Out Chinook Therapeutics

    12:03 p.m. July 7, 2022

    - Seeking Alpha

  2. 4 Small Stocks to Bet on in an Upbeat Drugs Industry

    9:32 a.m. July 6, 2022

    - Zacks.com

  3. Here's Why Momentum in Chinook (KDNY) Should Keep going

    8:50 a.m. June 27, 2022

    - Zacks.com

  4. GRPN, GNCA and LAB among mid-day movers

    12:49 p.m. May 25, 2022

    - Seeking Alpha

  5. Chinook Therapeutics stock slides on $105M equity offering

    5:33 a.m. May 25, 2022

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/kdny

Press Releases on KDNY

  1. Chinook Therapeutics Announces Proposed Public Offering

    4:03 p.m. May 24, 2022

    - GlobeNewswire

  2. FRX Innovations Commences Trading on the TSX Venture Exchange

    7:00 a.m. May 24, 2022

    - TheNewswire.ca

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.